What drugs target Alpha-4 beta-2 nicotinic acetylcholine receptor?

5+ drugs target Alpha-4 beta-2 nicotinic acetylcholine receptor, including Varenicline (VAR), Standard Duration Varenicline, Varenicline (Champix), Varenicline Pill, Varinecline (Chantix).

What drug classes act on Alpha-4 beta-2 nicotinic acetylcholine receptor?

Drug classes acting on Alpha-4 beta-2 nicotinic acetylcholine receptor include Nicotinic receptor partial agonist.

Alpha-4 beta-2 nicotinic acetylcholine receptor — Drug Target

5 drugs 5 marketed

All drugs that target Alpha-4 beta-2 nicotinic acetylcholine receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Nicotinic receptor partial agonist

Marketed (5)

Varenicline (VAR) · University of Oklahoma · Nicotinic receptor partial agonist · Addiction/Smoking Cessation
Varenicline is a partial agonist at the alpha-4 beta-2 nicotinic acetylcholine receptor that reduces nicotine cravings and blocks the rewarding effects of smoking.
Standard Duration Varenicline · University of Wisconsin, Madison · Nicotinic receptor partial agonist · Addiction/Smoking Cessation
Varenicline is a partial agonist at the alpha-4 beta-2 nicotinic acetylcholine receptor that reduces nicotine cravings and blocks the rewarding effects of nicotine.
Varenicline (Champix) · University of British Columbia · Nicotinic receptor partial agonist · Addiction/Smoking Cessation
Varenicline is a partial agonist at the alpha-4 beta-2 nicotinic acetylcholine receptor that reduces nicotine cravings and blocks the rewarding effects of smoking.
Varenicline Pill · National Institute on Drug Abuse (NIDA) · Nicotinic receptor partial agonist · Addiction/Smoking Cessation
Varenicline is a partial agonist at the alpha-4 beta-2 nicotinic acetylcholine receptor that reduces nicotine cravings and blocks the rewarding effects of nicotine.
Varinecline (Chantix) · American University of Beirut Medical Center · Nicotinic receptor partial agonist · Psychiatry / Addiction Medicine
Varenicline is a partial agonist at the alpha-4 beta-2 nicotinic acetylcholine receptor that reduces nicotine cravings and blocks the rewarding effects of smoking.